Acute low back pain (ALBP) remains one of the most common causes of disability, lost workdays, and emergency room visits in the United States. Yet despite its prevalence, there is still tremendous variation in how patients are evaluated and treated across the country. In an important step toward improving consistency, safety, and outcomes, a new national clinical practice guideline is currently in development—and you have an opportunity to contribute.
The Pacific Northwest Evidence-based Practice Center (PNW-EPC) at Oregon Health & Science University (OHSU) has partnered with the American Academy of Pain Medicine (AAPM) to develop an evidence-based guideline focused specifically on the assessment and management of acute low back pain. This project is supported by a grant from the U.S. Food and Drug Administration (FDA) and represents one of the most comprehensive national efforts to date to address the early stages of back pain.
Why This Guideline Matters
Low back pain affects nearly every demographic and accounts for billions of dollars in healthcare spending annually. Yet patients often receive conflicting recommendations depending on where they seek care. Some may be over-imaged, others may be under-assessed. Some receive timely interventional or rehabilitative care, while others receive treatments that are not evidence-supported.
This guideline aims to change that by providing clinicians—primary care physicians, interventional pain specialists, chiropractors, physical therapists, and emergency providers—with a unified, research-backed approach.
A rigorous two-year process has been undertaken, involving:
- A multidisciplinary team of pain specialists, methodologists, pharmacists, physical medicine physicians, primary care clinicians, and patient advocates
- A full systematic review of the current evidence
- Structured stakeholder engagement and expert consultation
- Iterative drafting and clinical applicability testing
The result is a DRAFT GUIDELINE and DRAFT SYSTEMATIC REVIEW now ready for public comment.
What the Public Comment Period Means for Clinicians
The development committee is now asking healthcare professionals to review the draft documents and provide feedback through an online submission form. This is an important opportunity for pain specialists—including interventional pain physicians—to help refine national standards in a way that reflects real-world challenges and aligns guideline recommendations with practical, patient-centered care.
Here’s what the EPC team is specifically seeking:
- Feedback on clarity and organization
- Suggestions regarding clinical applicability
- Identification of areas needing additional explanation
- Real-world insights on treatment pathways and feasibility
- Considerations for diverse patient populations
These comments will be aggregated, reviewed, and applied to the guideline prior to final publication.
How to Participate
Public comment is open until December 10, 2025, and submissions must be made through the official online comment portal. Emailed comments or document uploads are not accepted.
For interventional pain management clinicians, this is a rare chance to influence national decision-making and ensure that the final guideline reflects the full spectrum of evidence-based, multimodal, and minimally invasive care options available for acute low back pain.
The Bottom Line
The upcoming guideline represents a pivotal moment in modernizing how the U.S. approaches acute low back pain. By participating in the public comment process, clinicians can help ensure that patients receive the safest, most effective, and most consistent care possible. Our practice strongly encourages all colleagues in pain management and related specialties to review the draft documents and contribute to shaping this important national standard.
